Page last updated: 2024-08-22

tantalum and Coronary Restenosis

tantalum has been researched along with Coronary Restenosis in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abizaid, A; Almonacid, AP; Brar, S; Chamié, D; Kirtane, AJ; Maehara, A; Meredith, IT; Shetty, S; Simon, DI; Sinhal, A; Stone, GW; Windecker, S; Worthley, SG1
Lowe, R; Menown, IB; Nogareda, G; Penn, IM1
Abizaid, A; Costa, Jde R; Feres, F; Hattori, K; Larracas, C; Popma, JJ; Schwartz, LB; Solberg, B; Tanajura, LF1

Reviews

1 review(s) available for tantalum and Coronary Restenosis

ArticleYear
Coronary stents: in these days of climate change should all stents wear coats?
    Heart (British Cardiac Society), 2005, Volume: 91 Suppl 3

    Topics: Carbon; Carbon Compounds, Inorganic; Chromium Alloys; Coronary Restenosis; Heparin; Humans; Metals; Phosphorylcholine; Silicon Compounds; Stents; Tantalum

2005

Trials

1 trial(s) available for tantalum and Coronary Restenosis

ArticleYear
First-in-Human Evaluation of a Novel Polymer-Free Drug-Filled Stent: Angiographic, IVUS, OCT, and Clinical Outcomes From the RevElution Study.
    JACC. Cardiovascular interventions, 2017, 01-23, Volume: 10, Issue:2

    Topics: Australia; Chromium Alloys; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Thrombosis; Coronary Vessels; Drug Therapy, Combination; Drug-Eluting Stents; Female; Humans; Latin America; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Predictive Value of Tests; Prosthesis Design; Risk Factors; Singapore; Sirolimus; Tantalum; Time Factors; Tomography, Optical Coherence; Treatment Outcome; Ultrasonography, Interventional

2017

Other Studies

1 other study(ies) available for tantalum and Coronary Restenosis

ArticleYear
Clinical and angiographic results of percutaneous coronary revascularization using a trilayer stainless steel-tantalum-stainless steel phosphorylcholine-coated stent: the TriMaxx trial.
    Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2007, Dec-01, Volume: 70, Issue:7

    Topics: Aged; Angioplasty, Balloon, Coronary; Brazil; Cardiovascular Agents; Cardiovascular Diseases; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Feasibility Studies; Female; Germany; Humans; Male; Middle Aged; Phosphorylcholine; Prospective Studies; Prosthesis Design; Severity of Illness Index; Stainless Steel; Tantalum; Time Factors; Treatment Outcome

2007